860693P

C24:0 Ceramide (d18:2(4E,8Z)/24:0)

Avanti Research^™ - A Croda Brand 860693P, powder

• Synonym(e): N-lignoceroyl-D-erythro-sphingosine (d18:2(4E,8Z) base)
• Empirische Formel (Hill-System): C₄₂H₈₁NO₃
• Molekulargewicht: 648.10
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 1 mg (860693P-1mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860693P
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: OC[C@@](NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=C\CCCCCCCCC

Beschreibung

Allgemeine Beschreibung

C24:0 Ceramide (d18:2(4E,8Z)/24:0), also known as N-lignoceroyl-D-erythro-sphingosine (d18:2(4E,8Z) base), is a very long chain plasma ceramide derived from sphingosine containing two double bonds with lignoceric acid.

Biochem./physiol. Wirkung

Altered levels of C24:0 Ceramide has been observed in mild cognitive impairment (MCI) patients. It acts as a primary biomarker of Alzheimer disease (AD) progression.

Verpackung

5 mL Amber Glass Screw Cap Vial (860693P-1mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): No data available
• Flammpunkt (°C): No data available